We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.27%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$8.87B
AUM Growth
+$1.06B
(+14%)
Cap. Flow
+$639M
Cap. Flow
% of AUM
7.2%
Top 10 Holdings %
Top 10 Hldgs %
4.17%
Holding
3,246
New
442
Increased
1,245
Reduced
1,198
Closed
351
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Okta
OKTA
|
+$37.2M |
| 2 |
Linde
LIN
|
+$31.4M |
| 3 |
Take-Two Interactive
TTWO
|
+$30M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$27.4M |
| 5 |
Walmart Inc
WMT
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$46.1M |
| 2 |
PayPal
PYPL
|
+$31.4M |
| 3 |
Apple
AAPL
|
+$31.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$28M |
| 5 |
Merck
MRK
|
+$27.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Consumer Discretionary | 15.85% |
| 3 | Healthcare | 13.89% |
| 4 | Industrials | 12.4% |
| 5 | Financials | 11.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Griffon
GFF
$4.75B
| $327K | ﹤0.01% |
12,746
-14,564
| -53% | -$389K |
|
2277
InnovAge Holding
INNV
$1.47B
| $326K | ﹤0.01% |
+15,315
| New | +$350K |
|
2278
Coty
COTY
$2.52B
| $325K | ﹤0.01% |
34,760
-698,826
| -95% | -$6.35M |
|
|
SQZ
2279
DELISTED
SQZ Biotechnologies Company
SQZ
| $325K | ﹤0.01% |
+22,524
| New | +$294K |
|
|
GRTS
2280
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $324K | ﹤0.01% |
35,524
+572
| +2% | +$5.29K |
|
2281
nLIGHT
LASR
$2.89B
| $323K | ﹤0.01% |
8,908
-63,238
| -88% | -$1.89M |
|
2282
Vuzix
VUZI
$222M
| $323K | ﹤0.01% |
17,620
-45,475
| -72% | -$918K |
|
|
PRO
2283
DELISTED
PROS Holdings
PRO
| $322K | ﹤0.01% |
+7,065
| New | +$313K |
|
|
RPT
2284
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $322K | ﹤0.01% |
24,812
-959
| -4% | -$12.2K |
|
|
ESPR
2285
DELISTED
Esperion Therapeutics
ESPR
| $319K | ﹤0.01% |
15,085
-26,044
| -63% | -$627K |
|
2286
Vertex
VERX
$1.97B
| $319K | ﹤0.01% |
+14,556
| New | +$296K |
|
2287
Scorpio Tankers
STNG
$3.84B
| $318K | ﹤0.01% |
14,427
-26,229
| -65% | -$533K |
|
|
TTCF
2288
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $318K | ﹤0.01% |
14,815
-142,226
| -91% | -$2.79M |
|
|
BNR
2289
Burning Rock Biotech
BNR
$115M
| $317K | ﹤0.01% |
+1,078
| New | +$319K |
|
|
DVAX
2290
DELISTED
Dynavax Technologies
DVAX
| $317K | ﹤0.01% |
32,199
-21,458
| -40% | -$195K |
|
2291
Genius Sports
GENI
$2.07B
| $317K | ﹤0.01% |
+16,900
| New | +$335K |
|
2292
Usana Health Sciences
USNA
$265M
| $317K | ﹤0.01% |
3,095
-2,960
| -49% | -$297K |
|
2293
VistaGen Therapeutics
VTGN
$11.8M
| $317K | ﹤0.01% |
3,355
+79
| +2% | +$5.85K |
|
2294
Cardiff Oncology
CRDF
$80.9M
| $315K | ﹤0.01% |
47,344
-44,679
| -49% | -$379K |
|
2295
DXP Enterprises
DXPE
$3.06B
| $315K | ﹤0.01% |
9,464
-1,329
| -12% | -$41K |
|
2296
Enterprise Financial Services Corp
EFSC
$2.37B
| $315K | ﹤0.01% |
+6,787
| New | +$332K |
|
2297
Southside Bancshares
SBSI
$957M
| $315K | ﹤0.01% |
+8,240
| New | +$336K |
|
2298
Tanger
SKT
$4.44B
| $315K | ﹤0.01% |
16,709
-44,973
| -73% | -$789K |
|
|
EVOP
2299
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $315K | ﹤0.01% |
11,346
-38,948
| -77% | -$1.11M |
|
2300
Enova International
ENVA
$6.29B
| $314K | ﹤0.01% |
9,164
-37,406
| -80% | -$1.32M |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q2 2021 Portfolio in Review
As of Q2 2021, Cubist Systematic Strategies held 3,246 positions worth $8.87B, up 14% from $7.81B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
Cubist Systematic Strategies deployed $639M of net new capital in Q2 2021, opening 442 new positions and adding to 1,245 existing holdings. Its largest new stake was American Tower: 39,022 shares worth $10.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Aptiv, an estimated $46.1M trimmed.
- Cubist Systematic Strategies's largest Q2 2021 buy was American Tower: 39,022 shares worth $10.5M.
- Cubist Systematic Strategies added most to Okta in Q2 2021, an estimated $37.2M increase.
- Cubist Systematic Strategies's biggest Q2 2021 reduction was Aptiv, cutting an estimated $46.1M.
- Cubist Systematic Strategies fully exited Toro Company in Q2 2021, selling an estimated $7.31M.
- Cubist Systematic Strategies's ten largest holdings make up 4.2% of its $8.87B portfolio in Q2 2021.
- Cubist Systematic Strategies opened 442 new positions and closed 351 in Q2 2021.
- Cubist Systematic Strategies's portfolio value rose 14% quarter-over-quarter to $8.87B.
Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.